MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-08-2026
Pacific Biosciences of California Cash and Cash Equivalents 2011-2026 | PACB
Annual Cash and Cash Equivalents Pacific Biosciences of California
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.7 M | 55.4 M | 180 M | 325 M | 461 M | 81.6 M | 29.6 M | 18.8 M | 16.5 M | 16.8 M | 33.6 M | 36.4 M | 26.4 M | 46.5 M | 58.9 M | 148 M | 89.2 M | 78.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 461 M | 16.5 M | 98.1 M |
Quarterly Cash and Cash Equivalents Pacific Biosciences of California
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.3 M | 56.5 M | 54.8 M | 58.5 M | 55.4 M | 78 M | 99.5 M | 76.6 M | 180 M | 386 M | 209 M | 354 M | 325 M | 304 M | 310 M | 429 M | 461 M | 425 M | 460 M | 932 M | 81.6 M | 81.6 M | 81.6 M | 81.6 M | 29.6 M | 29.6 M | 29.6 M | 29.6 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 932 M | 16.5 M | 113 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 18.56 | - | $ 196 M |  China |
 |
Agilent Technologies
A
|
1.48 B | $ 113.26 | - | $ 34.4 B |  USA |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 1.63 | - | $ 2.17 M | USA |
 |
Castle Biosciences
CSTL
|
117 M | $ 18.88 | - | $ 547 M | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 16.19 | - | $ 490 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 20.49 | - | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
359 M | $ 96.67 | - | $ 6.52 B | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 419.17 | - | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | China |
 |
Mettler-Toledo International
MTD
|
66.9 M | $ 1 041.91 | - | $ 21.5 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
150 M | $ 3.62 | - | $ 335 M | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 8.36 | - | $ 1.07 B | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 18.93 | - | $ 424 M | USA |
 |
Natera
NTRA
|
466 M | $ 196.91 | - | $ 19.4 B | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 159.12 | - | $ 7.89 B | USA |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 25.5 | - | $ 24.2 B |  Niderland |
 |
Guardant Health
GH
|
378 M | $ 98.66 | - | $ 12.4 B | USA |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 5.82 | - | $ 243 M | USA |
 |
Personalis
PSNL
|
124 M | $ 6.71 | - | $ 599 M | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 117.09 | - | $ 9.66 B |  Irlanda |
 |
Illumina
ILMN
|
1.13 B | $ 143.24 | - | $ 22.8 B | USA |
 |
Soleno Therapeutics
SLNO
|
70.1 M | $ 52.99 | - | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
2.4 M | $ 2.41 | - | $ 5.54 M | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 448.21 | - | $ 169 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 254.02 | - | $ 21.1 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.58 | - | $ 208 M | Irlanda |
 |
Celcuity
CELC
|
166 M | $ 134.72 | - | $ 6.3 B | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 52.95 | - | $ 3.17 B | USA |
 |
Neogen Corporation
NEOG
|
129 M | $ 8.43 | - | $ 1.83 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 187.94 | - | $ 20.9 B | USA |